The current and future burden of hepatitis B in Switzerland: a modelling study
CONCLUSIONS: Thanks to the historical vaccination programmes and the continued rollout of universal 3-dose coverage in the first year of life, Switzerland is expected to exceed the global health sector strategy targets for the reduction of incidence. While overall prevalence is decreasing, the current diagnosis and treatment levels remain below global health sector strategy targets.PMID:37410921 | DOI:10.57187/smw.2023.40086
Source: Swiss Medical Weekly - Category: General Medicine Authors: Francesco Negro Beat M üllhaupt David Semela Sarah Blach Philip Bruggmann Andrea De Gottardi Jean-Francois Dufour Montserrat Fraga Antonio Galante Homie Razavi Joana Vieira Barbosa Devin Razavi-Shearer Source Type: research
More News: Cancer & Oncology | Carcinoma | Children | Cirrhosis | General Medicine | Hepatitis | Hepatitis B | Hepatitis Vaccine | Hepatocellular Carcinoma | History of Medicine | International Medicine & Public Health | Liver | Liver Cancer | Statistics | Study | Switzerland Health | Urology & Nephrology | Vaccines